Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,760 shares of the insurance provider's stock, valued at approximately $460,000.
A number of other hedge funds have also modified their holdings of AMSF. Allspring Global Investments Holdings LLC bought a new stake in AMERISAFE in the 1st quarter valued at $509,000. Mirae Asset Global Investments Co. Ltd. grew its stake in AMERISAFE by 12.5% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,524 shares of the insurance provider's stock valued at $818,000 after buying an additional 1,731 shares during the last quarter. Deutsche Bank AG grew its stake in AMERISAFE by 52.0% in the 4th quarter. Deutsche Bank AG now owns 18,610 shares of the insurance provider's stock valued at $959,000 after buying an additional 6,366 shares during the last quarter. Nuveen Asset Management LLC grew its stake in AMERISAFE by 92.1% in the 4th quarter. Nuveen Asset Management LLC now owns 161,815 shares of the insurance provider's stock valued at $8,340,000 after buying an additional 77,582 shares during the last quarter. Finally, Franklin Resources Inc. acquired a new position in AMERISAFE in the 4th quarter valued at about $359,000. 97.41% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the stock. JMP Securities reissued a "market outperform" rating and issued a $65.00 price objective on shares of AMERISAFE in a report on Wednesday, April 30th. Truist Financial cut their price target on shares of AMERISAFE from $54.00 to $50.00 and set a "hold" rating for the company in a report on Monday, July 28th. Finally, Wall Street Zen raised shares of AMERISAFE from a "sell" rating to a "hold" rating in a report on Saturday, July 26th.
Read Our Latest Stock Analysis on AMERISAFE
AMERISAFE Stock Performance
AMSF stock traded up $0.56 during mid-day trading on Tuesday, hitting $45.23. The company had a trading volume of 123,408 shares, compared to its average volume of 145,714. The firm has a market cap of $858.92 million, a PE ratio of 17.13 and a beta of 0.39. The stock's fifty day moving average price is $44.73 and its two-hundred day moving average price is $47.94. AMERISAFE, Inc. has a 12 month low of $42.48 and a 12 month high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The insurance provider reported $0.53 earnings per share for the quarter, missing analysts' consensus estimates of $0.55 by ($0.02). AMERISAFE had a return on equity of 16.54% and a net margin of 16.46%. The business had revenue of $79.70 million during the quarter, compared to the consensus estimate of $77.30 million. Equities analysts anticipate that AMERISAFE, Inc. will post 2.45 earnings per share for the current year.
AMERISAFE Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 26th. Stockholders of record on Friday, September 12th will be given a $0.39 dividend. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 3.4%. AMERISAFE's dividend payout ratio is currently 59.09%.
About AMERISAFE
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.